Holen Sie sich die Stockscreener-App
21.31
8.07%
-1.87
Handel nachbörslich:
21.31
Schlusskurs vom Vortag:
$23.18
Offen:
$22.33
24-Stunden-Volumen:
154.32K
Relative Volume:
0.53
Marktkapitalisierung:
$393.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.97%
1M Leistung:
-38.71%
6M Leistung:
+21.77%
1J Leistung:
+0.00%
1-Tages-Spanne:
$21.13
$22.89
1-Wochen-Bereich:
$21.13
$24.21
52-Wochen-Spanne:
$15.00
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Vergleichen Sie TECX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.31 | 393.00M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 128.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.83 | 81.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.00 | 34.69B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.07 | 30.17B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
242.66 | 26.02B | 3.32B | -860.46M | -1.04B | -8.32 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Tectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Is Tectonic Therapeutic, Inc. (TECX) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given Average Rating of "Buy" by Brokerages - MarketBeat
Tectonic Therapeutic, Inc. (TECX): Among the Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
11 Most Expensive Stocks Insiders Are Buying Recently - Insider Monkey
Tectonic Therapeutic to Participate in March Investor Conferences - The Manila Times
Exclusive Access: Tectonic's Management Team Opens Door to Investors at Major March Conferences - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Analyzing Fresh Tracks Therapeutics (NASDAQ:FRTX) and Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Timothy A. Springer Buys 129,294 Shares - MarketBeat
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (NASDAQ:TECX) Trading Down 3.2%Should You Sell? - MarketBeat
Daniel Lochner Acquires 4,617 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Contrasting Tectonic Therapeutic (NASDAQ:TECX) and Vir Biotechnology (NASDAQ:VIR) - Defense World
Major Stock Purchases Signal Strong Confidence in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater
Petri Dish: VC firm's new $340M seed fund; Watertown biotech raises $185M - The Business Journals
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $80.50 - Defense World
Tectonic announces ~$185M capital raise - MSN
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Given New $112.00 Price Target at Wells Fargo & Company - MarketBeat
TECX (Tectonic Therapeutic Inc) may reap gains as insiders became active recently - Knox Daily
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Up 6.7% Following Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Tectonic secures $185 million in private equity funding - MSN
Tectonic Therapeutic to Raise $185 Million Via Private Investment in Public Equity Financing - Marketscreener.com
Tectonic Therapeutic Secures $185 Million in PIPE Deal - TipRanks
Tectonic Therapeutic announces $185M private placement - TipRanks
Tectonic Announces $185 Million Private Placement - The Manila Times
Tectonic secures $185 million in private equity funding By Investing.com - Investing.com UK
Tectonic Therapeutic, Inc. Announces $185 Million Private Investment in Public Equity Financing - Nasdaq
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $112.00 - Defense World
Tectonic Therapeutic reports ‘positive’ data from Phase 1b trial for TX45 - TipRanks
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):